NYMC Faculty Publications
Frequency of Infusion-Related Reactions with CPX-351 Treatment in an Observational Study in Adults with Newly Diagnosed Therapy-Related AML or AML with Myelodysplasia-Related Changes (AML-MRC)
Author Type(s)
Faculty
DOI
10.1080/10428194.2021.1919668
Journal Title
Leukemia & Lymphoma
First Page
2539
Last Page
2542
Document Type
Article
Publication Date
10-2021
Department
Medicine
Keywords
Adult, Cytarabine, Daunorubicin, Humans, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes
Disciplines
Medicine and Health Sciences
Recommended Citation
Jacoby, M. A., Finn, L., Emadi, A., Saba, N. S., Powell, B. L., Seiter, K., Garcia, R., Faderl, S., & Male, H. J. (2021). Frequency of Infusion-Related Reactions with CPX-351 Treatment in an Observational Study in Adults with Newly Diagnosed Therapy-Related AML or AML with Myelodysplasia-Related Changes (AML-MRC). Leukemia & Lymphoma, 62 (10), 2539-2542. https://doi.org/10.1080/10428194.2021.1919668